You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》美銀證券下調莫德納(MRNA.US)目標價至175美元 評級「中性」
阿思達克 05-05 11:25
美銀證券發表研報指,莫德納(MRNA.US)今年首季表現穩健,新冠疫苗收入增長的推動下,收入及盈利均有所上升,雖然業績向好,仍有投資者對公司次季新冠相關業務收入指引及全年目標感到失望。 美銀表示,目前仍然對新冠相關業務發展持審慎看法,有待管理層進行更進一步解說。展望未來產品管線,該行對莫德納的下一步增長未有沒有明確的看法,考慮到季節性流感疫苗mRNA-1010的延遲,以及對其療效的擔憂,美銀相應下調季節性流感相關收入預測,目標價降至175美元,重申「中性」評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account